In ABC DLBCL, MYD88L265P frequently co-occurs with mutations in CD79B and this co-occurrence is even more pronounced in primary extranodal large cell lymphomas highlighting the convergence of BCR and TLR signaling in ABC-DLBCL (27, 40). This evidence concerns the gene BCR and diffuse large B-cell lymphoma.